Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 48 of 58, showing 10 Applications out of 576 total, starting on record 471, ending on 480

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

471.

ECCT/15/10/01   VRC01 Monoclonal HIV Antibodies Study
    Safety  and  Virologic Effect  Of  A  Human   Monoclonal   Antibody,   VRC-HIVmAb060-00-Ab  (VRCOl),   With Broad  HIV-1  Neutralizing Activity, Administered Intravenously to Adults  During Early Acute HIV Infection.   
Principal Investigator(s)
1. Josphat K Kosgei
Site(s) in Kenya
KEMRI Walter Reed Project Kericho
 
20-03-2016 View

472.

ECCT/15/12/05   Post-discharge Malaria Chemoprevention(PMC) study
    Malaria Chemoprevention with monthly treatment with dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: A 3-year, multi-centre, parallel-group, two-arm randomised placebo controlled superiority trial   
Principal Investigator(s)
1. Titus Kwambai
2. Simon Kariuki
Site(s) in Kenya
1. Siaya County Referral Hospital (Siaya county)
2. Homa Bay County Referral Hospital (Homa Bay county)
3. Migori County Referral Hospital (Migori county)
4. Busia County Referral Hospital (Busia county)
 
24-02-2016 View

473.

ECCT/15/10/04   AZM
    Azithromycin (AZM) to prevent post-discharge    morbidity and mortality in Kenyan children   
Principal Investigator(s)
1. Judd Walson Walson
Site(s) in Kenya
1. Homa Bay County referral Hospital (Homa Bay county)
2. Kisii Teaching and referral Hospital (Kisii county)
 
09-02-2016 View

474.

ECCT/15/11/05   FALCI Study
    A Randomized, Double-blind, Phase IIb Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine (FQ) with Artefenomel (OZ439) in Adults and Children with Uncomplicated Plasmodium falciparum Malaria.   
Principal Investigator(s)
1. Grace Kiringa Kaguthi
Site(s) in Kenya
1. KEMRI Center for Respiratory Diseases Research (Siaya county)
2. KEMRI Walter Reed Kombewa (Kisumu county)
3. KEMRI Kisumu (Kisumu county)
 
01-02-2016 View

475.

ECCT/15/11/04   VAC040
    A Phase 1/2, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety, Tolerability, and Immunogenicity of Stretococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide (PATH-wSP) in Healthy Kenya Young Adults (18 - 40years) and Toddlers (12 - 19months)   
Principal Investigator(s)
1. John Anthony Gerard Scott
Site(s) in Kenya
KEMRI-Wellcome Trust Research Program
 
09-02-2016 View

476.

ECCT/15/08/01   Rifapentine During Intensive Phase TB Treatment
     Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: a randomized, open-label, controlled, phase 3 clinical trial   
Principal Investigator(s)
1. Elisha Ochieng Okeyo
Site(s) in Kenya
KEMRICDC, KISUMU, KENYA
 
05-05-2016 View

477.

ECCT/15/10/03   Safer Conception Intervention for Partners (SCIP)
    Pilot of an mHealth-enhanced, safer conception intervention to reduce HIV-1 risk among Kenyan HIV-1 serodiscordant couples   Safer Conception Intervention for Partners (SCIP)   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
Thika Partners Study Clinic (Partners in Health Research and Development) affiliated to the University of Washington International Clinical Research Center (ICRC), and KEMRI
 
11-01-2016 View

478.

ECCT/15/09/01   NuvaRing Study
    Effects of contraceptive ring on vaginal microbiota, HIV shedding and local immunity   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
Thika Partners Study Clinic (Partners in Health Research and Development) affiliated to the University of Washington International Clinical Research Center (ICRC), and KEMRI
 
16-02-2016 View

479.

ECCT/15/06/02   ZINC in Sickle cell study
    The effects of Zinc supplementation in children with sickle cell disease in Western Kenya: a pilot study.   
Principal Investigator(s)
1. Lucas Otieno Tina
Site(s) in Kenya
Health Facilities in Western Kenya
 
17-08-2015 View

480.

ECCT/15/06/01  
    Pyronaridine-artesunate and artemether-lumefantrine for the treatment of paediatric uncomplicated falciparum malaria in Western Kenya   
Principal Investigator(s)
1. Patrick Sawa
Site(s) in Kenya
St. Judes Clinic, ICIPE
 
04-09-2015 View